The role of monoclonal antibodies in the treatment of lupus nephritis

Key Points

• To evaluate the role and impact of monoclonal antibodies in treating lupus nephritis.
• Reviewed emerging monoclonal antibody therapies for lupus nephritis
• Analyzed current treatment options and their accessibility
• Discussed the need for future trials and studies for better treatment algorithms
• Identified high costs and limited access as barriers to first-line use of new agents
• Noted the importance of long-term data for effective treatment strategies
• Highlighted the necessity for head-to-head trials to refine therapies

Abstract